We firstly analyzed the IL-1β and lncRNA CHRF expression profile in the cells and tissues of patients with NSCLC to elucidate the potential role of IL-1β and lncRNA CHRF in the pathogenesis of this disease. This evidence concerns the gene IL1B and non-small cell lung carcinoma.